Back to trial details

Intake questionnaire

MRX-2843 and Osimertinib for the Treatment of Advanced EGFR Mutant Non-small Cell Lung Cancer

Applying to Emory University Hospital/Winship Cancer Institute · Atlanta, Georgia

Answer a few short questions to share with the research team.

0 of 3 answered

1. Are you 18 years old or older?
2. Have you been diagnosed with Advanced Lung Non-Small Cell Carcinoma?
3. Are you able to travel to Atlanta for study visits?